Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices

J Heart Lung Transplant. 2014 Mar;33(3):316-8. doi: 10.1016/j.healun.2013.12.008. Epub 2013 Dec 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Female
  • Follow-Up Studies
  • Gastrointestinal Hemorrhage / epidemiology
  • Heart Failure / therapy*
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Thrombosis / epidemiology*
  • Thrombosis / prevention & control*
  • Warfarin / adverse effects
  • Warfarin / therapeutic use
  • Withholding Treatment*

Substances

  • Anticoagulants
  • Warfarin
  • Aspirin